Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-12-22 10:09 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318,026
+24,558 vol $12.95 each |
462,443 | |
Filed 2023-12-22 10:08 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$219,174
+12,589 vol $17.41 each |
437,885 | |
Filed 2022-12-20 16:24 Tx date 2022-12-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$101,485
+13,000 vol $7.81 each |
425,296 | |
Filed 2022-05-25 10:18 Tx date 2022-05-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,550
+1,000 vol $6.55 each |
412,296 | |
Filed 2022-05-21 10:14 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,250
+2,500 vol $6.90 each |
411,296 | |
Filed 2022-05-16 10:19 Tx date 2022-05-13 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$207,705
+30,000 vol $6.92 each |
408,796 | |
Filed 2022-05-13 13:13 Tx date 2022-05-12 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$203,077
+30,516 vol $6.65 each |
378,796 | |
Filed 2022-03-09 11:49 Tx date 2022-03-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$127,949
+15,000 vol $8.53 each |
348,280 | |
Filed 2022-03-09 08:37 Tx date 2022-03-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$369,449
+45,584 vol $8.10 each |
333,280 | |
Filed 2021-11-09 14:38 Tx date 2021-11-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,387
+8,100 vol $12.39 each |
287,696 | |
Filed 2021-09-01 10:32 Tx date 2021-08-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$299,993
+32,608 vol $9.20 each |
279,596 | |
Filed 2021-09-01 10:31 Tx date 2021-08-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-299,993.60
-32,608 vol $9.20 each |
457,392 | |
Filed 2021-05-26 15:31 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+100,000 vol |
100,000 | |
Filed 2021-05-26 15:06 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-26 09:53 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,088,256
+49,287 vol $22.08 each |
490,000 | |
Filed 2021-05-20 11:43 Tx date 2021-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,000
+3,000 vol $19.00 each |
246,988 | |
Filed 2021-05-20 11:43 Tx date 2021-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,568
+2,000 vol $18.28 each |
243,988 | |
Filed 2020-05-20 13:14 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,719,113
+98,573 vol $17.44 each |
440,713 | |
Filed 2020-01-27 13:13 Tx date 2020-01-27 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,445
+3,300 vol $11.65 each |
234,488 | |
Filed 2020-01-09 16:00 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-135,000 vol |
15,000 | |
Filed 2020-01-09 15:59 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,288,751 vol |
476,528 | |
Filed 2020-01-09 15:58 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-871,200 vol |
96,800 | |
Filed 2020-01-08 12:24 Tx date 2020-01-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,478,268
+134,388 vol $11.00 each |
1,102,388 | |
Filed 2020-01-08 12:22 Tx date 2020-01-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,478,268
-134,388 vol $11.00 each |
4,630,891 | |
Filed 2019-05-21 13:34 Tx date 2019-05-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,840,000
+2,000,000 vol $0.92 each |
4,765,279 | |
Filed 2018-12-04 Tx date 2018-12-03 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,914
+89,700 vol $0.66 each |
904,000 | |
Filed 2018-12-04 Tx date 2018-12-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,910
+64,000 vol $0.69 each |
968,000 | |
Filed 2018-09-28 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,009
+137,000 vol $0.72 each |
814,300 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$105,000
+75,000 vol $1.40 each |
150,000 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+150,000 vol $1.00 each |
677,300 | |
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+150,000 vol $1.00 each |
527,300 | |
Filed 2017-09-22 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$105,000
+75,000 vol $1.40 each |
75,000 | |
Filed 2016-12-28 Tx date 2016-12-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,781
+44,300 vol $1.08 each |
377,300 | |
Filed 2016-12-22 Tx date 2016-12-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,559,341
+1,417,583 vol $1.10 each |
||
Filed 2016-12-22 Tx date 2016-12-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,559,341
+1,417,583 vol $1.10 each |
2,765,279 | |
Filed 2016-12-13 Tx date 2016-12-13 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,300
+9,300 vol $1.00 each |
333,000 | |
Filed 2016-12-09 Tx date 2016-12-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,300
+9,300 vol $1.00 each |
323,700 | |
Filed 2016-12-08 Tx date 2016-12-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+3,900 vol $1.00 each |
314,400 | |
Filed 2016-12-05 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,030
+227,300 vol $1.10 each |
227,300 | |
Filed 2016-12-05 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,063
+227,330 vol $1.10 each |
||
Filed 2016-12-02 Tx date 2016-12-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,700
+43,700 vol $1.00 each |
310,530 | |
Filed 2016-12-02 Tx date 2016-12-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,500
+39,500 vol $1.00 each |
266,830 | |
Filed 2016-11-28 Tx date 2016-11-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$400,555
+364,141 vol $1.10 each |
1,347,696 | |
Filed 2016-11-28 Tx date 2016-11-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
$400,555
+364,141 vol $1.10 each |
||
Filed 2016-11-15 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,063
+227,330 vol $1.10 each |
227,330 | |
Filed 2016-11-15 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,275
+16,500 vol $1.35 each |
983,555 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,770
+16,500 vol $1.38 each |
||
Filed 2016-09-16 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,770
+16,500 vol $1.38 each |
983,555 | |
Filed 2016-08-23 Tx date 2016-08-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,363,720
+934,055 vol $1.46 each |
967,055 | |
Filed 2016-05-31 Tx date 2016-05-18 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+281,900 vol |
826,900 | |
Filed 2016-05-31 Tx date 2016-05-18 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,540,664
+281,900 vol $12.56 each |
||
Filed 2016-05-25 Tx date 2016-05-18 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units (RSU)
56 - Grant of rights
|
+47,120 vol |
47,120 | |
Filed 2016-05-25 Tx date 2005-06-03 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-05-20 Tx date 2016-05-18 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,540,664
+281,900 vol $12.56 each |
826,900 | |
Filed 2016-04-12 Tx date 2016-04-12 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Computershare (Control or Direction)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+6,149 vol |
6,149 | |
Filed 2016-04-12 Tx date 2005-06-03 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Computershare (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-12-07 Tx date 2015-12-04 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-95,000
-10,000 vol $9.50 each |
545,000 | |
Filed 2015-12-07 Tx date 2015-12-04 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$95,000
+10,000 vol $9.50 each |
558,507 | |
Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+33,000 vol |
33,000 | |
Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-15 Tx date 2015-05-13 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,551,600
+120,000 vol $12.93 each |
555,000 | |
Filed 2015-05-12 Tx date 2015-05-11 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,990
+9,380 vol $10.66 each |
548,507 | |
Filed 2015-05-05 Tx date 2015-05-04 |
$NDQ
Novadaq Technologies Inc. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,958
+4,630 vol $12.95 each |
539,127 |